Cartesian Therapeutics (RNAC) Earnings Date, Estimates & Call Transcripts $17.02 -0.10 (-0.58%) (As of 11/14/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cartesian Therapeutics Latest Earnings SummaryUpcoming Earnings DateMar. 6EstimatedActual EPS (Aug. 8) $0.54 Beat By $1.35 Consensus EPS (Aug. 8) -$0.81 Cartesian Therapeutics announced Q2 2024 earnings on August 8, 2024, reporting an EPS of $0.54, which topped the consensus estimate of -$0.81 by $1.35. Quarterly revenue was reported to be $33.45 million, above analyst estimates of $6 million. With a trailing EPS of -$52.83, Cartesian Therapeutics' earnings are expected to grow next year, from ($4.07) to ($3.01) per share. Earnings Press ReleaseRNAC Upcoming EarningsCartesian Therapeutics' next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules. Get Cartesian Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cartesian Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRNAC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RNAC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Cartesian Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$1.34-$0.27-$0.81Q2 20242-$0.95-$0.33-$0.64Q3 20242-$0.95-$0.36-$0.66Q4 20242-$0.85-$0.42-$0.64FY 20248-$4.09-$1.38-$2.74Q1 20251-$0.47-$0.47-$0.47Q2 20251-$0.49-$0.49-$0.49Q3 20251-$0.52-$0.52-$0.52Q4 20251-$0.58-$0.58-$0.58FY 20254($2.06)($2.06)($2.06) Cartesian Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/6/2025(Estimated)------- 8/8/2024--$0.81$0.54+$1.35$0.54$6.00M$33.45M 5/8/2024Q1 2024-$0.81-$1.97 -$1.16$6.56-$5.84M 3/7/2024Q4 2023-$0.30-$2.40 -$2.10$1.23-$8.27M 11/13/2023Q3 2023-$1.05-$1.20 -$0.15-$0.10$9.70M$6.55M8/17/2023Q2 2023-$1.35-$1.05+$0.30-$0.07$9.90M$5.25M 5/4/2023Q1 2023-$1.20-$1.65 -$0.45-$0.08$14.60M$5.94M Get the Latest News and Ratings for RNAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/2/2023Q4 2022-$0.60-$0.45+$0.15-$0.10$12.72M$16.80M Cartesian Therapeutics Earnings - Frequently Asked Questions When is Cartesian Therapeutics's earnings date? Cartesian Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on RNAC's earnings history. Did Cartesian Therapeutics beat their earnings estimates last quarter? In the previous quarter, Cartesian Therapeutics (NASDAQ:RNAC) reported $0.54 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.81) by $1.35. Learn more on analysts' earnings estimate vs. RNAC's actual earnings. How much revenue does Cartesian Therapeutics generate each year? Cartesian Therapeutics (NASDAQ:RNAC) has a recorded annual revenue of $54.10 million. How much profit does Cartesian Therapeutics generate each year? Cartesian Therapeutics (NASDAQ:RNAC) has a recorded net income of -$219.71 million. RNAC has generated -$52.83 earnings per share over the last four quarters. What is Cartesian Therapeutics's EPS forecast for next year? Cartesian Therapeutics's earnings are expected to grow from ($4.07) per share to ($3.01) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies IMCR Earnings Date OCUL Earnings Date KNSA Earnings Date DAWN Earnings Date SPRY Earnings Date XNCR Earnings Date RCUS Earnings Date NTLA Earnings Date RCKT Earnings Date TVTX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. This page (NASDAQ:RNAC) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNAC Stock Alerts